Inspira Technologies Expands U.S. Commercial Footprint with New Deployment at Top-Ranked New York Academic Medical Center.

Inspira Technologies has expanded its US commercial footprint by deploying its FDA-cleared INSPIRA ART100 system at a new academic medical center in New York, ranked among the top 10 in New York State. The deployment is part of a structured commercial evaluation to define clinical protocols and potential broader institutional adoption. This marks a continued execution of the company's US commercial strategy and demonstrates the ART100's suitability for top-tier US healthcare providers.